RxDoctor Payments Data

Ryan Szepiela, MD

Physical Medicine & Rehabilitation · Toledo, OHNPI 1295985349

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.6% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Pfizer at 24.7% of the total.

$2,563in general payments, 2019–2025

Across 148 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$632
  • AbbVie$604
  • Trice Medical, Inc.$355
  • Pacira Therapeutics, Inc.$156
  • Biohaven Pharmaceutical Holding Company Ltd.$134
  • Collegium Pharmaceutical, Inc.$87
  • plus $596 from 18 others

What the payments were for

  • Food & beverage$2,52799%
  • Education$361%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,563 in reported general payments places this provider in the 85th percentile of 332 physical medicine & rehabilitation providers in Ohio.

See all physical medicine & rehabilitation providers in Ohio

Medicare billing

Part B allowed, 2024
$303,950
Medicare patients
359
Services billed
15,138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen849$21,309
OxycontinOxycodone Hcl28$18,849
Pregabalin299$12,018
Xtampza ErOxycodone Myristate15$9,642
Hysingla ErHydrocodone Bitartrate14$9,592
Gabapentin639$9,550
SavellaMilnacipran Hcl11$7,562
Buprenorphine14$5,517
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen353$5,143
Fentanyl38$4,125
Celecoxib57$2,172
Oxycodone Hcl102$1,935
Tramadol Hcl ErTramadol Hcl25$1,741
Tramadol Hcl250$1,642
Morphine Sulfate ErMorphine Sulfate55$1,385

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$87$9,64215 claims
AbbVieSavella$604$7,56211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 332 physical medicine & rehabilitation providers in Ohio.

Other physical medicine & rehabilitation in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →